HLA class II and autoimmunity: Epitope selection vs differential expression

Acta Histochemica

Volumn 111, Issue 4, 2009, Pages 380-382

  Müller Hilke, Brigitte ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Autoimmunity; HLA; Promoter polymorphism

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 2; HLA ANTIGEN;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; PATHOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; PSORIASIS; RHEUMATOID ARTHRITIS; ANIMAL; GENETICS; IMMUNOLOGY; REVIEW;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; EPITOPES; HAPLOTYPES; HLA ANTIGENS; HUMANS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 68949204931     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2008.11.011     Document Type: Article

References (14)

1. Baumgart M., Moos V., Schuhbauer D., and Muller B. Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects. Proc Natl Acad Sci USA 95 12 (1998) 6936-6940
2. Glimcher L.H., and Kara C.J. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 10 (1992) 13-49
3. Gregersen P.K., Silver J., and Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30 11 (1987) 1205-1213
4. Guardiola J., Maffei A., Lauster R., Mitchison N.A., Accolla R.S., and Sartoris S. Functional significance of polymorphism among MHC class II gene promoters. Tissue Antigens 48 6 (1996) 615-625
5. Heldt C., Listing J., Sozeri O., Blasing F., Frischbutter S., and Muller B. Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis. Arthritis Rheum 48 10 (2003) 2779-2787
6. Hosken N.A., Shibuya K., Heath A.W., Murphy K.M., and O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 182 5 (1995) 1579-1584
7. Lang B., Melchers I., Urlacher A., Tanzi-Fetta R.F., Kohlbrenner S., Tongio M.M., et al. HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients. Rheumatol Int 10 4 (1990) 171-175
8. Liblau R.S., Singer S.M., and McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16 1 (1995) 34-38
9. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., et al. Nomenclature for factors of the HLA system, 2004. Hum Immunol 66 5 (2005) 571-636
10. Mitchison N.A., Ono S.J., and Stephens H.A. Does the polymorphism of MHC class II promoters matter?. Cell Immunol 233 2 (2005) 162-165
11. Müller-Hilke B., and Mitchison N.A. The role of HLA promoters in autoimmunity. Curr Pharm Des 12 29 (2006) 3743-3752
12. Svejgaard A., Platz P., and Ryder L.P. HLA and disease 1982-a survey. Immunol Rev 70 (1983) 193-218
13. van Roon J.A., Bijlsma J.W., and Lafeber F.P. Diversity of regulatory T cells to control arthritis. Best Pract Res Clin Rheumatol 20 5 (2006) 897-913
14. Weyand C.M., McCarthy T.G., and Goronzy J.J. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95 5 (1995) 2120-2126